PET respiratory motion correction: quo vadis?


Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 02 06 2021
accepted: 16 12 2021
pubmed: 17 12 2021
medline: 6 5 2022
entrez: 16 12 2021
Statut: epublish

Résumé

Positron emission tomography (PET) respiratory motion correction has been a subject of great interest for the last twenty years, prompted mainly by the development of multimodality imaging devices such as PET/computed tomography (CT) and PET/magnetic resonance imaging (MRI). PET respiratory motion correction involves a number of steps including acquisition synchronization, motion estimation and finally motion correction. The synchronization steps include the use of different external device systems or data driven approaches which have been gaining ground over the last few years. Patient specific or generic motion models using the respiratory synchronized datasets can be subsequently derived and used for correction either in the image space or within the image reconstruction process. Similar overall approaches can be considered and have been proposed for both PET/CT and PET/MRI devices. Certain variations in the case of PET/MRI include the use of MRI specific sequences for the registration of respiratory motion information. The proposed review includes a comprehensive coverage of all these areas of development in field of PET respiratory motion for different multimodality imaging devices and approaches in terms of synchronization, estimation and subsequent motion correction. Finally, a section on perspectives including the potential clinical usage of these approaches is included.

Identifiants

pubmed: 34915465
doi: 10.1088/1361-6560/ac43fc
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 Institute of Physics and Engineering in Medicine.

Auteurs

F Lamare (F)

Nuclear Medicine Department, University Hospital of Bordeaux, Bordeaux, F-33000, France.
University of Bordeaux, CNRS, EPHE, INCIA, UMR 5287, Talence, F-33400, France.

A Bousse (A)

LaTIM, INSERM, UMR 1101, Université de Bretagne Occidentale, F-29238 Brest, France.

K Thielemans (K)

Institute of Nuclear Medicine, University College London, London, United Kingdom.
Centre for Medical Imaging Computing, University College London, United Kingdom.

C Liu (C)

Department of Radiology and Biomedical Imaging, Yale University, New Haven, United States of America.

T Merlin (T)

LaTIM, INSERM, UMR 1101, CHRU de Brest, F-29238 Brest, France.

H Fayad (H)

Weill Cornell Medicine-Qatar, Doha, Qatar.
OHS, NM, Hamad Medical Corporation, Doha, Qatar.

D Visvikis (D)

LaTIM, INSERM, UMR 1101, Université de Bretagne Occidentale, F-29238 Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH